Ureteroscope Market Size:
The Global Ureteroscope Market is expected to grow from US$721.856 million in 2025 to US$943.842 million in 2030, at a CAGR of 5.51%.
A ureteroscope is a small instrument inserted into the bladder and ureter to diagnose and treat a variety of problems in the urinary tract. The purview of ureteroscopy has broadened from diagnostic endoscopy to various minimally invasive procedures. Growth in the ureteroscope market is significantly driven by the rising incidence of urolithiasis, coupled with the increasing prevalence of urologic cancers. Also, the growing adoption and demand for minimally invasive procedures are anticipated to play a crucial role in augmenting the market growth during the forecast period. Moreover, the rise in research and development activities in ureteroscopes is expected to boost the growth of the global ureteroscope market. However, the high cost of ureteroscope is expected to hinder the market growth. Furthermore, the rising prevalence of obesity, diabetes, and a growing geriatric population are expected to surge the incidences of diseases of the urinary tract, which in turn is anticipated to propel the global ureteroscope market growth during the assessment period.
The recent outbreak of the novel coronavirus disease had a negative impact on the global ureteroscope market. The pandemic shifted the major focus of the healthcare system towards COVID-19, and as part of the COVID-19 restrictions, a large number of surgeries had to be cancelled in many parts of the world, which led to a decline in the global ureteroscope market in 2020. However, as the restrictions are being eased in most parts of the world, the market is anticipated to recover and continue at its normal pace from the year 2022 onwards.
One of the major factors anticipated to drive the growth of the global ureteroscope market during the forecast period is the growing number of cases of urolithiasis, which is expected to surge the demand for ureteroscopes. According to an article published in the Journal of Family Medicine and Primary Care in December 2020, the prevalence of urolithiasis has been increasing around the world with a prevalence of 7–13% in North America, 5-9% in Europe 5–9%, and 1-5% in Asia. It also states that the United States will have an expected additional expenditure of $1.24 billion/year by 2030 due to a rise in the number of cases of urolithiasis. An article published by Advanced Biomedical Research in the US National Library of Medicine, National Institutes of Health, showed that diabetes increases the risk of urolithiasis. As perthe International Diabetes Federation, 9.3% of the global population, i.e., 463 million people, had diabetes in 2019, which is projected to increase to 10.2%, i.e., 578 million, by 2030 and 10.9% i.e., 700 million by 2045. This is leading to an increased prevalence of urolithiasis, which is anticipated to propel the growth of the global ureteroscope market during the assessment period.
The rise in the adoption and demand for minimally invasive surgeries, due to their various advantages over traditional surgeries, is prompting increased use of ureteroscopes, which is anticipated to propel the growth of the global ureteroscope market during the forecast period. The minimally invasive surgery requires smaller incisions and consequently less scar tissue, which are some of the reasons for its rising preference. Minimally invasive surgeries reduce the hospital stay time for the patient and have shorter recovery periods, along with providing increased accuracy, which is prompting the demand for minimally invasive surgeries. Another article published in February 2020 in the US NLM, NIH, showed that open surgical procedures declined by nearly 35% from 2000 to 2018 and are being replaced by minimally invasive surgeries. This rising demand is expected to grow further in the coming years and is anticipated to boost the global ureteroscope market growth during the forecast period.
Geographically, the North American region is anticipated to hold a significant market share owing to a large presence of conditions that lead to urolithiasis and other complications requiring the use of a ureteroscope. The United States has a high prevalence of diabetes, which increases the risk of urolithiasis, which is one of the reasons for the high market share of North America. Also, the presence of an advanced healthcare system contributed to the domination of North America in the global ureteroscope market. The Asia Pacific region is anticipated to witness substantial growth due to rising cases of urolithiasis in the region and the increasing number of people with obesity. Also, the increased expenditure in the healthcare industry is further anticipated to propel the market growth in the Asia Pacific during the forecast period.
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Report Metric | Details |
| Ureteroscope Market Size in 2025 | US$721.856 million |
| Ureteroscope Market Size in 2030 | US$943.842 million |
| Growth Rate | CAGR of 5.51% |
| Study Period | 2020 to 2030 |
| Historical Data | 2020 to 2023 |
| Base Year | 2024 |
| Forecast Period | 2025 – 2030 |
| Forecast Unit (Value) | USD Million |
| Segmentation |
|
| Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| List of Major Companies in Ureteroscope Market |
|
| Customization Scope | Free report customization with purchase |